Company Information & Drug Savings for Aveo Pharmaceuticals Medications
AVEO Oncology is a biopharmaceutical company focused on developing targeted cancer therapies. The company created FOTIVDA (tivozanib), an oral VEGF receptor tyrosine kinase inhibitor approved for relapsed or refractory advanced renal cell carcinoma (kidney cancer). AVEO’s precision oncology approach targets tumor angiogenesis and specific molecular pathways in cancer progression.
How to Contact Aveo Pharmaceuticals
Phone
1-617-588-1600Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
Experienced a Side Effect?
Report to Yellow Card (UK) or MedWatch (US)
